
Russia's first experimental surgery for Alzheimer's disease was performed in Tomsk.
The first Alzheimer's surgery in Russia was performed in Tomsk. The effectiveness of the method has not yet been proven.
What did Tomsk surgeons do?
Specialists Tomsk Research Institute of Microsurgery done The patient underwent deep cervical lymphatic bypass, an intervention that is thought to slow neurodegenerative processes.
The operation lasted approximately three hours and was performed under a microscope. Surgeons connected vessels less than 1 mm in diameter to the lymphatic system of the neck. This is believed to improve the outflow of fluid from the brain and the removal of waste products.
The method is already being used in China.
The method is not new. The first such operation for Alzheimer's disease was performed in 2020 in China. Hangzhou, and since then the approach has quickly spread: by 2025, 382 clinics in 32 regions were offering it China. The studies were also registered in Singapore.
Why the effectiveness of the operation has not been proven
But there is almost no evidence base for this method. Published work These are series of one to 26 patients, without randomization or comparison groups; none of the studies included sham surgery. Follow-up in most cases lasted less than a month, six months at most. This is insufficient to isolate the outcome of the intervention from natural fluctuations in the patient's condition and from the placebo effect, which is particularly strong during surgery. Possible complications include damage to the recurrent laryngeal nerve, rupture of the internal jugular vein, and narrowing of the anastomosis.
What do the doctor's say
Doctors are currently monitoring the patient. According to the microsurgeon Andrey Baitinger, The operation was a significant development for Russian medicine. Specialists hope the method will become more widely available.
How many people live with Alzheimer's disease?
Alzheimer's disease is the most common cause of dementia. According to the WHO, in 2021, there were approximately 57 million people worldwide with dementia, with Alzheimer's disease accounting for 60–70% of cases—that's 34–40 million people.